Kyntra Bio (KYNB)

• Market cap: $29M
• 1 day: -0.28%
• 5 days: -0.97%
• 1 month: 0.56%
• 3 months: -20.95%
• 6 months: -32.04%
• Year to date: -21.72%
• 1 year: 10.48%
• 5 years: -98.56%
• 10 years: -98.59%
• Sector: Healthcare
• Industry: Biotechnology

About: Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Employees: 34